Prne
March 10th, 2009
CLEVELAND and ZURICH, Switzerland - Simbionix and VirtaMed Have Joined Forces to Provide OB/GYN Surgeons
the Most Advanced Training System for Endoscopic Surgery
- The New VirtaMed HystSim(TM) Simulator Adds Hysteroscopy to Simbionix’
Impressive Line of Medical Simulation and eLearning Products
Simbionix, the world’s leading developer of medical simulation systems,
and VirtaMed, a Swiss medical engineering company, announced today a global
collaboration agreement. Simbionix will exclusively distribute, market, and
provide service for the VirtaMed HystSim, an advanced virtual reality
hysteroscopy simulator.
Simbionix already offers a wide spectrum of simulators for minimal
invasive surgery. “This new agreement further expands our product offering,”
says Simbionix CEO Gary Zamler. “The addition of the HystSim simulator, along
with our recently launched laparoscopic surgery module for gynecology, shows
how seriously Simbionix is investing in women’s healthcare issues.”
Simbionix’ President and founder, Mr. Ran Bronstein, adds: “Our
simulation technology is definitely a revolution in the world of medical
training and assessment. We are happy to be working together with VirtaMed, a
company as committed to technology and simulation quality as we are.
Simbionix will keep increasing its product offering to the medical community
and bring quality and service to its customers and partners.”
“VirtaMed is thrilled to be working together with Simbionix, the market
leader in surgical simulation,” adds VirtaMed CEO Stefan Tuchschmid.
“Simbionix is a partner that will ensure the HystSim simulator is available
globally. We truly appreciate Simbionix’ commitment to provide the best
possible training for surgeons in every field.”
VirtaMed HystSim(TM) will be officially launched at the next ACOG
(American College of Obstetricians and Gynecologists) annual clinical
meeting held in Chicago on May 2nd.
Further information and product demonstrations are available from your
local Simbionix sales representative and at www.simbionix.com.
About VirtaMed
VirtaMed is a Swiss based company with an interdisciplinary background in
medicine and engineering. The HystSim(TM) system is the first VirtaMed
product and provides instructional teaching and training of diagnostic and
therapeutic hysteroscopy. VirtaMed’s mission is to develop state-of-the-art
training tools for endoscopic surgery of highest possible realism, all with
the ultimate goal to improve the quality of patient care. Additional company
information can be found at www.virtamed.com.
About Simbionix
Simbionix is a global leader in medical simulation technology. Simbionix
mission is to provide state of the art, computer-assisted metrics-based
surgical simulation systems, and set the standard for minimally invasive
surgical training and performance.
Simbionix products provide medical experts with hands-on training in a
comprehensive array of MIS procedures, including; GI Endoscopy, Endourology,
percutaneous access, advanced laparoscopic procedures and Endovascular
procedures. Visit www.simbionix.com
Contact:
Inbal Mazor
VP Marketing
Simbionix
inbal@simbionix.com
Tel: +972-8-9211177
Source: Simbionix Ltd.
Contact: Inbal Mazor, VP Marketing, Simbionix, inbal at simbionix.com, Tel: +972-8-9211177
Filed under Biotechnology, Clinical Trials / Medical Discoveries, Contracts, Health, Health Care / Hospitals, Investors, Joint Ventures, Medical Equipment, Pharmaceuticals | Tags: Cleveland and zurich, College, Europe, Switzerland, United States of America | Comment Below
Related Press Releases Simbionix USA Corporation's Innovative Development Division Releases Two New Breakthrough TechnologiesSeptember 20th, 2009 CLEVELAND, Ohio - Simbionix USA Corporation, the world's leading developer of medical simulation systems, just released two new products: a new Laparoscopic Essential Tasks Module for its LAP Mentor(TM) and a breakthrough technology for patient-specific simulation based on actual patient data - the PROcedure Rehearsal Studio(TM). The new Laparoscopic Essential Tasks Module is an addition to the LAP Mentor's ever-expanding library of modules. Patients Fear Osteoporosis Quality of Life Impact, Yet Lack Tools to Manage Concerns and Improve Osteoporosis Outcomes, New Survey SaysSeptember 13th, 2009 DENVER -
- International Osteoporosis Foundation (IOF) launches OsteoLink to address unmet needs in osteoporosis management through digital and in-person patient and physician communication networks across Europe and Australia
The International Osteoporosis Foundation (IOF) today announced results from a new multinational survey of patients (n= 844; women 55+ with post menopausal osteoporosis) and physicians (n= 837; general practitioners and specialists treating osteoporosis) at the 31st annual meeting of the American Society of Mineral and Bone Research (ASBMR). Results show that patients fear the impact of osteoporosis on quality of life, such as breaking a bone and reduced activity, far more than physicians believe. Accumetrics' VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patient's Response to Newly-Approved Prasugrel (Effient(R))July 13th, 2009 SAN DIEGO, California -
With the recent FDA approval of the new P2Y12 inhibitor, prasugrel (Effient), Accumetrics, Inc. announces that its VerifyNow P2Y12 Test is not only able to assess response to Plavix(R), but also its newly approved competitor, Effient. European Consumers Share a High Interest in Healthcare, but Hold Varied Views on Many Health IssuesJuly 13th, 2009 NEW YORK -
- New TNS Healthcare Study Reveals Both Differences and Similarities in Health Views across Europe
More than 90% of consumers across the five major European markets -- the UK, France, Italy, Germany and Spain -- share an interest in health, according to a new study by TNS Healthcare, a Kantar Health Company. European woman are significantly more concerned with health than men, with 95% of females expressing interest in health issues vs. Simbionix Signs Agreement With the European Association for Endoscopic SurgeryJune 29th, 2009 PRAGUE - Prague Convention Center - Simbionix and the European Association for Endoscopic Surgery (EAES) have signed an agreement to collaborate on the development of training materials and assessment tools for a new Laparoscopic Skills Curriculum. Since its founding in 1990, the EAES has played a leading role in the promotion and dissemination of endoscopic surgery and allied interventional techniques throughout Europe. Accumetrics, Inc. Announces Distribution Channels in Israel and CyprusJune 8th, 2009 SAN DIEGO - Accumetrics, Inc. announces today it has signed new distribution agreements for its VerifyNow(R) System in both Israel and Cyprus. Simbionix and B-Line Medical(R) Announce Multi-Level AgreementMay 4th, 2009 CLEVELAND Ohio, and WASHINGTON DC - Simulation Technology Leader and the Leading Developer of Simulation-based Healthcare Training Platforms Form Cooperative Agreement
Simbionix USA Corporation and B-Line Medical, LLC, today announced a strategic agreement enabling the data integration of Simbionix Mentor(TM) simulation systems with B-Line Medical's SimCapture(R) product. The collaboration will combine Simbionix' unique data collected during a simulation session with video streams into the SimCapture system for debriefing, assessing and centralizing multiple types of simulated encounters. Elsevier Launches Ten New eBook Specialty Collections on MD ConsultApril 28th, 2009 ST. LOUIS, Missouri - Increases Accessibility to Market-Leading Specialty Content
Elsevier, the world's leading publisher of scientific, technical, and medical information products and services, announced today that ten new eBook Specialty Collections have launched on MD Consult (www.mdconsult.com), its online clinical reference tool. This launch provides online availability of market-leading specialty content in Dermatology, Dermatologic Surgery, Family Medicine, General Radiology, Geriatric Medicine, Hand Surgery, Neonatology, Otolaryngology, Pathology, and Shoulder Surgery. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS CountriesApril 16th, 2009 CLEVELAND, Ohio - Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products. Johnson & Johnson LLC, a subsidiary of Johnson & Johnson, operates in Russia, the Ukraine, and other CIS countries. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS CountriesApril 15th, 2009 CLEVELAND, Ohio - Simbionix, the world's leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix's simulators and related products. Johnson & Johnson, LLC operates in Russia, Ukraine and CIS countries and is one of the subsidiaries of Johnson & Johnson.
Related News Initial public offerings scheduled to debut next weekApril 24th, 2009 Initial public offerings scheduled to debutNEW YORK — The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.ipohome.com) and SEC filings. Ordering physicians lack knowledge of CT-related radiation exposure riskApril 24th, 2009 WASHINGTON - A new study conducted at the Carilion Clinic in Roanoke, VA, has found that majority of ordering physicians lack knowledge of CT-related radiation exposure and its associated risks. "More than 100 surveys were completed by physicians from various specialties who order CT scans at a tertiary-care teaching hospital," said Jeremy McBride, MD, lead author of the study. A mere touch of an object can make you buy itApril 1st, 2009 WASHINGTON - Want to avoid making unnecessary purchases? Well, then keep your hands off the object, for a new study has shown that merely touching an item increases the feelings of ownership people have for the object, prompting them to purchase it. In 2003 Illinois state attorney general's office had warned holiday shoppers to be cautious of retailers who encourage them to hold objects and imagine the objects as their own when shopping. UAL to launch offerings of 19 million common shares and $175M in notesSeptember 30th, 2009 UAL to launch public offering of stock and notesNEW YORK — The parent company of United Airlines, UAL Corp., says it plans to offer 19 million shares and $175 million in convertible senior notes due 2029 in a pair of public offerings. Shares fell 60 cents, or 6.5 percent, to $8.62 in aftermarket trading. Bajaj two-wheeler sales down 5 percentJuly 2nd, 2009 NEW DELHI - India's second largest two-wheeler maker Bajaj Auto Thursday said its sales dipped 5 percent last month to 168,471 units, comparing to 177,112 units sold in June 2008. However, the company's three-wheeler sales rose 26 percent to 24,731 units last month from 19,629 units in the like period last year. Product Recalls: Crouton productMay 2nd, 2009 Product Recalls: Crouton productThe following recall has been announced:
—Sugar Foods Corp. is recalling 531 cases of The Farmers Market Butter & Garlic crouton product because the croutons could contain undeclared milk allergens. Labour induction doesn't necessarily increases caesarean riskAugust 18th, 2009 WASHINGTON - Debunking an age-old belief, a group of researchers in the U.S. have found that inducing labour does not necessarily increase a woman's risk for caesarean section delivery in childbirth. Photronics says it will offer at least 6.3M in new stock and $50M in notes due 2014September 9th, 2009 Photronics plans to sell stock and senior notesBROOKFIELD, Conn. — Photronics Inc. Product Recalls: yogurtAugust 12th, 2009 Product Recalls: yogurtThe following recall has been announced:
— Liberte Brand Products is recalling 6-ounce Liberte Mediterranee Wild Blackberry Yogourt products with the code date of Sept. 2. The product might contain walnuts and plums not declared on its packaging. One in three women risk rape in crisis-hit DarfurJune 1st, 2009 DARFUR - A human rights charity survey has found that one in three women fleeing from the civil war hit region of Darfur in Sudan risk being rape victims. The US-based, Physicians For Human Rights, interviewed 88 women who had fled from Darfur and came to a conclusion that rape against women was widespread, Sky News reports.
|
|
